Hybridization assays
Sensitive quantification using capture and detection strategies tailored to sequence and modifications.
← Bioanalysis ServicesOligonucleotides & Genetic Medicines
Nucleic Acids
Bioanalytical and quality-oriented support for oligonucleotides, siRNA, antisense candidates, mRNA-related constructs, and nucleic-acid based therapeutics.
OligonucleotidesHybridizationLC-MSqPCRLNP
Assays for sequence-driven medicines.
Nucleic acid therapeutics demand careful control of sequence specificity, extraction recovery, nuclease stability, and matrix effects. rebirthBiology configures platforms around analyte chemistry and required sensitivity.
LC-MS workflows
Mass-based characterization and quantitation support for oligonucleotide purity, metabolites, and impurities.
qPCR / molecular readouts
Platform support for vector, transcript, or sequence-related measurements where applicable.
Formulation support
Analytical testing around LNP-associated attributes, encapsulation questions, and stability-indicating needs.
Why Choose
Specificity first, sensitivity always.
Sequence awareness
Assays are selected to manage cross-hybridization, shortened metabolites, and modified backbones.
Platform flexibility
Hybridization, LC-MS, and molecular methods can be combined to answer different questions.
Development continuity
Bioanalysis and CMC perspectives are aligned for oligonucleotide programs.
Develop a nucleic acid assay strategy.
Send sequence class, modifications, matrix, expected concentration, and decision stage.
Start Nucleic Acid Support